Meta-Analysis Data Pooling May Mask Favorable Results - FDA's Temple
This article was originally published in The Tan Sheet
Pooling data for a meta-analysis of clinical trials could mask favorable results in specific settings, FDA Center for Drug Evaluation & Research Associate Director for Medical Policy Robert Temple, MD, says in a commentary piece published in the March 3 Journal of the American Medical Association.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC